In a cohort study of 63 patients with NAFLD, immunohistochemical analysis of pathological liver tissues showed that patients with chronic liver diseases had increased oxidative stress and high Nrf2 expression (Mohs et al., 2021). The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.